PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression

Area of Science:

• Biomaterials Science
• Gene Therapy
• Nanotechnology

Background:

• Poly(amidoamine) (PAMAM) dendrimers are effective nonviral gene carriers.
• High toxicity and limited in vivo efficacy hinder PAMAM dendrimer applications.
• Polyethylene glycol (PEG) conjugation is a strategy to improve biomaterial properties.

Purpose of the Study:

• To enhance the gene delivery characteristics of G5 and G6 PAMAM dendrimers.
• To evaluate the impact of PEGylation on PAMAM dendrimer toxicity and efficacy.
• To determine the optimal PEGylation ratio for improved gene delivery.

Main Methods:

• Conjugation of polyethylene glycol (PEG, MW 5,000) to G5 and G6 PAMAM dendrimers at 4%, 8%, and 15% molar ratios.
• Assessment of in vitro and in vivo cytotoxicity and hemolysis.
• Evaluation of gene expression in 293A cells (in vitro) and neonatal mouse quadriceps muscle (in vivo).

Main Results:

• PEG conjugation significantly reduced the cytotoxicity and hemolysis of G5 and G6 PAMAM dendrimers, particularly at higher PEG ratios.
• 8% PEG-conjugated G5 and G6 PAMAM dendrimers (G5-8% PEG, G6-8% PEG) demonstrated the highest efficiency in muscular gene expression.
• These PEGylated dendrimers also mediated superior in vitro transfection in 293A cells.

Conclusions:

• PEGylation effectively mitigates the toxicity of G5 and G6 PAMAM dendrimers.
• G5-8% PEG and G6-8% PEG exhibit significant potential as efficient gene delivery vectors.
• Optimized PEGylation offers a promising approach for developing safer and more effective gene delivery systems.